Capital Advisors Ltd’s TELA Bio TELA Stock Holding History

Capital Advisors Ltd’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-130	Closed	–	–	1573
2024 Q4	$0	Hold	130	–	–	﹤0.01%	1574
2024 Q3	$0	Buy	+130	New	+$462	﹤0.01%	1604

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Capital Advisors Ltd's TELA Position: Q1 2025 in Review

Capital Advisors Ltd sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 130 shares.

Capital Advisors Ltd first reported a position in TELA in Q3 2024 and held it in 2 quarters. The position peaked at $0 in Q4 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

Capital Advisors Ltd reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
Capital Advisors Ltd sold 130 TELA Bio shares in Q1 2025.
Capital Advisors Ltd first reported a position in TELA Bio in Q3 2024 and held it in 2 quarters.
Capital Advisors Ltd's TELA Bio position peaked at $0 in Q4 2024.
50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Capital Advisors Ltd's 13F filing for Q1 2025, filed 15 Apr 2025.